Skip to content

Akadeum Life Sciences

3 viewers · 30d

Total raised

$7.8M

+$2.1M this year

2 filings since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $2.1M
ROUNDS
2
INVESTORS
35
FOUNDED
N/A
HQ
Ann Arbor, MI
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
3

AI overview

Updated

Akadeum Life Sciences, Inc. is a biotechnology company that specializes in innovative cell separation technologies tailored for the life sciences industry. Its mission is to enhance the efficiency and scalability of vital sample preparation processes essential for research, diagnostics, and cell therapy applications.

What sets it apart

Akadeum's BACS™ microbubble technology represents a breakthrough in efficient and gentle cell isolation, addressing significant challenges in sample preparation.

Funding history

2 rounds
EquityJun 25, 2026
Form D
+$2.1M$7.8M total
Equity+2Apr 11, 2025
Form D
+$5.6M$5.6M total

Products

1 tracked

BACS™ Microbubble Technology

Cell Isolation

The Buoyancy Activated Cell Sorting (BACS™) microbubble technology is a flotation-based platform designed to improve the efficiency of cell isolation and sample preparation. It uses specialized microbubbles that attach to target cells, allowing them to float for gentle and effective separation.

  • Facilitates efficient isolation of specific cell populations such as T cells.
  • Can be applied in nucleic acid extraction and protein isolation.
  • Enhances sample preparation processes for research and diagnostics.
  • Maintains high cell viability during the separation process.